Latest filing published 14 Jun 2018 for BriaCell Therapeutics Corp., €7,477.
Filing timeline
BuySaleInsider track record
Rahoul Sharan: trading record in brief
Rahoul Sharan is a declared insider of BriaCell Therapeutics Corp., with filings sourced from SEC (Form 4). We count 45 filings; the first trade dates from 22 April 2016 and the latest from 14 June 2018.
The open-market side counts 36 purchases for €68k alongside 7 sales for €158k. Sales outweigh purchases by €90k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2018 alone, the filings show 4 purchases and 3 sales.
A typical purchase (the median) is worth €1,055. The 36 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The record was last updated on 14 June 2018 with an open-market purchase (€7,477) in BriaCell Therapeutics Corp. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Rahoul Sharan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 79,000 shares@ CA$0.1452.3% of flowCommon SharesTSXSEDI:3197153Canonical exit: 11 Sept 2018 (T+90)
- 21,000 shares@ CA$0.1450.6% of flowCommon SharesTSXSEDI:3197157Canonical exit: 12 Sept 2018 (T+90)
- 37,500 shares@ CA$0.120.9% of flowCommon SharesTSXSEDI:3156366Canonical exit: 17 Jun 2018 (T+90)
- 500,000 shares@ CA$0.1413.5% of flowCommon SharesTSXSEDI:3156205
- 62,500 shares@ CA$0.121.4% of flowCommon SharesTSXSEDI:3156370Canonical exit: 17 Jun 2018 (T+90)
- 106,000 shares@ CA$0.132.7% of flowCommon SharesTSXSEDI:3154004
- 89,000 shares@ CA$0.132.2% of flowCommon SharesTSXSEDI:3154000
- 195,000 shares@ CA$0.134.9% of flowCommon SharesTSXSEDI:3153993
- 25,000 shares@ CA$0.130.6% of flowCommon SharesTSXSEDI:3091000Canonical exit: 1 Mar 2018 (T+90)
- 500 shares@ CA$0.130.0% of flowCommon SharesTSXSEDI:3091001Canonical exit: 1 Mar 2018 (T+90)
- 5,000 shares@ CA$0.130.1% of flowCommon SharesTSXSEDI:3084814Canonical exit: 14 Feb 2018 (T+90)
- 24,500 shares@ CA$0.150.7% of flowCommon SharesTSXSEDI:3083565Canonical exit: 13 Feb 2018 (T+90)
- 10,000 shares@ CA$0.160.3% of flowCommon SharesTSXSEDI:3083563Canonical exit: 12 Feb 2018 (T+90)
- 10,000 shares@ CA$0.1350.3% of flowCommon SharesTSXSEDI:3067820Canonical exit: 2 Jan 2018 (T+90)
- 50,000 shares@ CA$0.1651.5% of flowCommon SharesTSXSEDI:3053016Canonical exit: 30 Nov 2017 (T+90)
- 20,000 shares@ CA$0.160.6% of flowCommon SharesTSXSEDI:3052991Canonical exit: 30 Nov 2017 (T+90)
- 50,000 shares@ CA$0.161.5% of flowCommon SharesTSXSEDI:3051239Canonical exit: 26 Nov 2017 (T+90)
- 200,000 shares@ CA$0.165.9% of flowCommon SharesTSXSEDI:3047809
- 2,000 shares@ CA$0.160.1% of flowCommon SharesTSXSEDI:3045209Canonical exit: 8 Nov 2017 (T+90)
- 3,000 shares@ CA$0.160.1% of flowCommon SharesTSXSEDI:3045208Canonical exit: 8 Nov 2017 (T+90)
- 10,000 shares@ CA$0.160.3% of flowCommon SharesTSXSEDI:3043580Canonical exit: 2 Nov 2017 (T+90)
- 2,000 shares@ CA$0.160.1% of flowCommon SharesTSXSEDI:3042593Canonical exit: 1 Nov 2017 (T+90)
- 500 shares@ CA$0.160.0% of flowCommon SharesTSXSEDI:3042556Canonical exit: 31 Oct 2017 (T+90)
- 1,500 shares@ CA$0.1650.0% of flowCommon SharesTSXSEDI:3040569Canonical exit: 25 Oct 2017 (T+90)
- 1,500 shares@ CA$0.1650.0% of flowCommon SharesTSXSEDI:3037538Canonical exit: 15 Oct 2017 (T+90)
25 of 45 declarations
